EPIDUO

LOE Approaching

adapalene and benzoyl peroxide

NDATOPICALGEL
Approved
Dec 2008
Lifecycle
LOE Approaching
Competitive Pressure
15/100
Clinical Trials
2

Mechanism of Action

protein. Biochemical and pharmacological profile studies have demonstrated that adapalene is a modulator of cellular differentiation, keratinization and inflammatory processes. However, the significance of these findings with regard to the mechanism of action of adapalene for the treatment of acne…

Pharmacologic Class:

Retinoid

Clinical Trials (2)

NCT04892706Phase 2Completed

Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel

Started Jun 2021
NCT00757523Phase 4Completed

Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris

Started Sep 2008
382 enrolled
Acne Vulgaris

Loss of Exclusivity

LOE Date
Jul 18, 2027
16 months away
Patent Expiry
Jul 18, 2027

Patent Records (3)

Patent #ExpiryTypeUse Code
8071644
Jul 18, 2027
Product
U-1078
8080537
Jul 18, 2027
U-1078
8129362
Jul 18, 2027
U-1078